Search research articles
Contact Us
Filters
Showing results (111-120 of 229) with videos related to
Page
of 23
Sort By:
Journal of Comparative Effectiveness Research
|
June 1, 2018
A decision framework for treating chronic immune thrombocytopenia with thrombopoietin receptor agonists
Mike Dolph, Anuja Roy, Menaka Bhor, et al.
Pharmacoeconomics
|
July 2, 2022
Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US
Hardik Goswami, Adnan Alsumali, Yiling Jiang, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
October 29, 2014
Cost-Effectiveness Uncertainty Analysis Methods: A Comparison of One-Way Sensitivity, Analysis of Covariance, and Expected Value of Partial Perfect Information
Jonathan D Campbell, R Brett McQueen, Anne M Libby, et al.
BMJ (Clinical Research Ed.)
|
February 5, 2008
Value based pricing for NHS drugs: an opportunity not to be missed?
Karl Claxton, Andrew Briggs, Martin J Buxton, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 31, 2022
Approaches for Enhanced Extrapolation of Long-Term Survival Outcomes Using Electronic Health Records of Patients With Cancer
Xiaoliang Wang, Blythe J Adamson, Andrew Briggs, et al.
Pharmacoeconomics
|
March 17, 2023
Correction to: Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US
Hardik Goswami, Adnan Alsumali, Yiling Jiang, et al.
International Journal of Rheumatology
|
January 29, 2010
Ankylosing spondylitis patients commencing biologic therapy have high baseline levels of comorbidity: a report from the Australian rheumatology association database
John Oldroyd, Lionel Schachna, Rachelle Buchbinder, et al.
Health Economics
|
June 19, 2023
Estimating health care costs at scale in low- and middle-income countries: Mathematical notations and frameworks for the application of cost functions
Marc d'Elbée, Fern Terris-Prestholt, Andrew Briggs, et al.
BMJ Open
|
August 20, 2017
Protocol for an economic evaluation of the randomised controlled trial of culprit lesion only PCI versus immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: CULPRIT-SHOCK trial
Zahidul Quayyum, Andrew Briggs, Jose Robles-Zurita, et al.
Journal of Health Economics and Outcomes Research
|
September 4, 2023
A Cost-effectiveness Analysis of Brentuximab Vedotin in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma
Margaret Hux, Denise Zou, Esprit Ma, et al.
Page
of 23
Search research articles
Search
Showing results (111-120 of 229) with videos related to
Sort By:
Page
of 23
Journal of Comparative Effectiveness Research
|
June 1, 2018
A decision framework for treating chronic immune thrombocytopenia with thrombopoietin receptor agonists
Mike Dolph, Anuja Roy, Menaka Bhor, et al.
Pharmacoeconomics
|
July 2, 2022
Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US
Hardik Goswami, Adnan Alsumali, Yiling Jiang, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
October 29, 2014
Cost-Effectiveness Uncertainty Analysis Methods: A Comparison of One-Way Sensitivity, Analysis of Covariance, and Expected Value of Partial Perfect Information
Jonathan D Campbell, R Brett McQueen, Anne M Libby, et al.
BMJ (Clinical Research Ed.)
|
February 5, 2008
Value based pricing for NHS drugs: an opportunity not to be missed?
Karl Claxton, Andrew Briggs, Martin J Buxton, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 31, 2022
Approaches for Enhanced Extrapolation of Long-Term Survival Outcomes Using Electronic Health Records of Patients With Cancer
Xiaoliang Wang, Blythe J Adamson, Andrew Briggs, et al.
Pharmacoeconomics
|
March 17, 2023
Correction to: Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US
Hardik Goswami, Adnan Alsumali, Yiling Jiang, et al.
International Journal of Rheumatology
|
January 29, 2010
Ankylosing spondylitis patients commencing biologic therapy have high baseline levels of comorbidity: a report from the Australian rheumatology association database
John Oldroyd, Lionel Schachna, Rachelle Buchbinder, et al.
Health Economics
|
June 19, 2023
Estimating health care costs at scale in low- and middle-income countries: Mathematical notations and frameworks for the application of cost functions
Marc d'Elbée, Fern Terris-Prestholt, Andrew Briggs, et al.
BMJ Open
|
August 20, 2017
Protocol for an economic evaluation of the randomised controlled trial of culprit lesion only PCI versus immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: CULPRIT-SHOCK trial
Zahidul Quayyum, Andrew Briggs, Jose Robles-Zurita, et al.
Journal of Health Economics and Outcomes Research
|
September 4, 2023
A Cost-effectiveness Analysis of Brentuximab Vedotin in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma
Margaret Hux, Denise Zou, Esprit Ma, et al.
Page
of 23